PE-backed Acadia to acquire Priory for almost $1.9 bln

By Iris Dorbian — 1 month ago

Acadia Healthcare Company Inc, which is backed by Waud Capital and Bain Capital, has agreed to acquire Priory Group, a UK-based provider of behavioral healthcare services. According to terms of the deal, Acadia will pay a cash consideration of about $1.887 billion. Jefferies advised Acadia on the transaction.

Continue

PE-backed Vertical/Trigen and Osmotica to merge

By Iris Dorbian — 2 months ago

Two pharmaceutical companies Vertical/Trigen Holdings LLC and Osmotica Holdings Corp Limited have agreed to merge. No financial terms were disclosed. Jefferies LLC provided financial advice to Osmotica on the transaction. Vertical/Trigen is a portfolio company of Avista Capital Partners.

Continue

Warburg Pincus to invest up to $300 mln into Vertice Pharma

By Iris Dorbian — 3 months ago

Warburg Pincus will invest up to $300 million into the newly launched Vertice Pharma, a specialty pharmaceuticals company based in both the UK and New Jersey. In addition to the financing, Don DeGolyer will join Vertice as CEO while Andrew Saik will become the company’s chief financial officer. Jefferies provided financial advice to Vertice Pharma on the transaction.

Continue

Advanced Accelerator Applications goes public

By Iris Dorbian — 3 months ago

Advanced Accelerator Applications, a French company that specializes in molecular nuclear medicine, has debuted its IPO after pricing its over 4.6 million shares at $16 per share. The stock began trading Wednesday on the NASDAQ under the ticker symbol “AAAP. Citigroup Global Markets Inc and Jefferies LLC are the lead underwriters. The company’s backers include HBM Healthcare Investments.

Continue

Thoma Bravo sells Embarcadero Technologies to Idera

By Iris Dorbian — 4 months ago

Thoma Bravo has sold San Francisco-based Embarcadero Technologies, a provider of software solutions for application and database development, to Idera Inc. No financial terms were disclosed for the deal that’s expected to be completed the middle of this month. Jefferies & Company Inc provided financial advice to Thoma Bravo on the transaction.

Continue

VC-backed Aclaris goes public

By Iris Dorbian — 4 months ago

Malvern, Pennsylvania-based Aclaris Therapeutics, a dermatology-focused specialty pharmaceutical company, has raised $55 million for its IPO after pricing its 5 million shares at $11 per share. The stock began trading Wednesday on the NASDAQ under the ticker symbol “ACRS.” Jefferies LLC and Citigroup Global Markets Inc are serving as the lead underwriters. Aclaris is backed by Vivo Ventures, Fidelity Biosciences and Sofinnova Ventures

Continue

H.I.G. Capital-backed Surgery Partners unveils IPO

By Iris Dorbian — 4 months ago

Surgery Partners, a portfolio company of H.I.G. Capital, has rolled out its IPO after pricing its 14.29 million shares at $19 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol “SGRY.” BofA Merrill Lynch, Goldman Sachs and Jefferies LLC are serving as lead underwriters. Surgery Partners is surgical services provider.

Continue

Z Capital exits MSDP Group

By Iris Dorbian — 5 months ago

Z Capital has sold MSDP Group to Lincolnshire-backed Holley Performance Products. No financial terms were disclosed. Jefferies was financial advisor to Z Capital on the transaction. Based in El Paso, Texas, MSDP is a provider of vehicle aftermarket performance parts.

Continue

Sentinel Capital buys Driven Performance Brands: UPDATED

By Luisa Beltran — 5 months ago

Sentinel Capital Partners said Friday that it has acquired Driven Performance Brands. Financial terms weren’t announced. Santa Rosa, California-based Driven Performance designs, makes and markets automotive aftermarket performance products for car and truck enthusiasts. UPDATE: Jonathan Carey of Jefferies advised Driven Performance Brands.

Continue

VC-backed CytomX Therapeutics files for IPO

By Iris Dorbian — 5 months ago

South San Francisco-based CytomX Therapeutics, a biopharmaceutical company focused on treating cancer, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be determined. The company plans on trading the stock on the NASDAQ under the ticker symbol “CTMX.” BofA Merrill Lynch, Jefferies LLC and Cowen and Company LLC will serve as the lead underwriters. CytomX’s backers include Fidelity Management & Research Company, Casdin Capital, Cormorant Asset Management, Deerfield Management, Perceptive Advisors, Redmile Group, Tekla Healthcare Investors and Tekla Life Sciences Investors, Venrock Healthcare Capital Partners and Wellington Management Company.

Continue

Arlington Capital to sell Novetta to Carlyle

By Iris Dorbian — 5 months ago

The Carlyle Group has agreed to acquire McLean, Virginia-based Novetta, a provider of advanced analytics solutions, from Arlington Capital Partners. No financial terms were disclosed. Morgan Stanley & Co LLC and Houlihan Lokey provided financial advice to Novetta and Arlington Capital Partners on the transaction while Jefferies was financial advisor to Carlyle.

Continue

Thoma Bravo to buy majority stake in DigiCert

By Iris Dorbian — 5 months ago

Thoma Bravo LLC has agreed to acquire a majority stake in Lehi, Utah-based DigiCert, a provider of trusted certificate management solutions. The seller is TA Associates, which will retain a minority stake in DigiCert as part of the transaction. No financial terms were disclosed. Jefferies LLC provided financial advice to Thoma Bravo while Evercore did likewise for DigiCert. Jefferies Finance LLC and Fifth Street Asset Management provided the financing for the deal.

Continue

Apax to acquire controlling stake in FULLBEAUTY Brands

By Iris Dorbian — 6 months ago

Apax Partners has agreed to acquire a controlling stake in FULLBEAUTY Brands, a provider of plus-size apparel. The sellers are Charlesbank Capital Partners and Webster Capital; however, Charlesbank will retain a “substantial” ownership stake in FULLBEAUTY after the transaction closes. No financial terms were disclosed. J.P. Morgan Securities LLC and Jefferies provided financial advice to FULLBEAUTY, Charlesbank and Webster Capital while Deutsche Bank did likewise for Apax.

Continue

Apax to invest in online real estate marketplace Idealista

By Iris Dorbian — 7 months ago

Apax Partners has agreed to acquire a stake in online real estate marketplace Idealista SA. The sellers are Tiger Global Management, Kutxabank and Bonsai Venture Capital. Jefferies provided financial advice to Idealista on the transaction while PricewaterhouseCoopers provided financial and tax advice to Apax.

Continue